Although the cardiovascular outcomes trial did not find an association between GLP-1 RAs and thyroid cancers [25], the recent FDA Adverse Event Reporting System (FAERS) database analysis confirmed a higher risk of thyroid cancer [21]. Here, GLP1R is linked to thyroid cancer.